WellSpring To Make U.S. Debut With Acquisition Of McNeil’s Micatin, Emetrol
This article was originally published in The Tan Sheet
Executive Summary
WellSpring Pharmaceutical Corporation will enter the U.S. OTC market with its purchase of the U.S. rights to several smaller brands from McNeil Consumer Healthcare